News Guest User 10/10/24 Guest User 10/10/24 Infensa researchers nominated for a national university award Read More Guest User 7/10/24 Guest User 7/10/24 Infensa drug candidate receives $17.8M funding to advance to clinical trials Read More Guest User 30/8/24 Guest User 30/8/24 Infensa wins KE Select Emerging Innovator of the Year at Life Sciences Queensland awards Read More Guest User 30/7/24 Guest User 30/7/24 Infensa Bioscience selected as a finalist for the 2024 KE Select Emerging Innovator Award by Life Sciences Queensland Read More Guest User 23/5/24 Guest User 23/5/24 Infensa CSO and co-founder Professor Glenn King elected a Fellow of the Australian Academy of Science Read More Guest User 5/3/24 Guest User 5/3/24 Brisbane startup Infensa spins medical miracle from spider venom Read More
Guest User 10/10/24 Guest User 10/10/24 Infensa researchers nominated for a national university award Read More
Guest User 7/10/24 Guest User 7/10/24 Infensa drug candidate receives $17.8M funding to advance to clinical trials Read More
Guest User 30/8/24 Guest User 30/8/24 Infensa wins KE Select Emerging Innovator of the Year at Life Sciences Queensland awards Read More
Guest User 30/7/24 Guest User 30/7/24 Infensa Bioscience selected as a finalist for the 2024 KE Select Emerging Innovator Award by Life Sciences Queensland Read More
Guest User 23/5/24 Guest User 23/5/24 Infensa CSO and co-founder Professor Glenn King elected a Fellow of the Australian Academy of Science Read More
Guest User 5/3/24 Guest User 5/3/24 Brisbane startup Infensa spins medical miracle from spider venom Read More
